Market Access Solved

Market Access success is more than just coding, coverage and payment. It must start early in the regulatory and clinical processes, and it culminates in effective value positioning, reimbursement opportunities, price maximization, competitive market uptake, revenue growth, and driving overall commercial success. In M&A/Investing diligence, it's all about verifying and validating. The Market Access Solved team specializes in M&A/Investor/Corporate Development due diligence, market access, reimbursement, clinical and regulatory assessments by applying our 85 combined years of US and International strategic and tactical expertise in medical devices, implants, human/xenograft/synthetic tissue products, durable medical equipment, biologics, and drug/device combination products. Market Access Solved offers expertise in: ∙ M&A / Investment Due Diligence for Venture Capital, Private Equity, and Corporate Business Development ∙ Reimbursement (Coding, Coverage & Payment) ∙ Code Applications for CPT and ICD-10-PCS Procedure Coding, and HCPCS Product Coding ∙ Medicare Alternative Payment Pathways (Inpatient NTAP, Outpatient Transitional Pass-Through, Outpatient New Technology APC) ∙ Health Economic / Budget Impact Positioning for Premium Pricing Opportunities ∙ Value Proposition, Value Messaging & Value Positioning ∙ Navigating Facility Value Analysis Committee (VAC) & Technology Assessments for New/Innovative Medical Device Technologies ∙ Strategies and Tactics for Attaining Medicare and Commercial Payer Coverage ∙ Clinical Study, Trial & Registry Design and Protocol Development to Generate Patient Reported Outcomes for Commercialization ∙ US FDA 510(k), De Novo 510(k), PMA Regulatory ∙ Country-Specific International Registration Pathways ∙ C-Suite, Executive Leadership & Corporate Board Education Let's connect to discuss how we can SOLVE your market access needs. Call me at +1 615-779-4174 or e-mail me at erik.harris@marketaccesssolved.com